Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
New Pediatric Labeling Information Database - Detail
FDA Home
Pediatrics
New Pediatric Labeling Information Database
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Pediatric Labeling Date:
06/17/2013
Trade Name:
Precedex
Generic Name or Proper Name (*):
dexmedetomidine hydrochloride
Indications Studied:
Loading and maintenance infusion for sedation in intubated and mechanically ventilated pediatric patients
Label Changes Summary:
Safety and efficacy have not been established for procedural or ICU sedation in pediatric patients One assessor-blinded trial in pediatric patients and two open label studies in neonates were conducted to assess efficacy for ICU sedation. These studies did not meet their primary efficacy endpoints and the safety data submitted were insufficient to fully characterize the safety profile of dexmedetomidine for this patient population Use for procedural sedation in pediatric patients has not been evaluated
Product Labeling:
Labeling
BPCA(B):
B
Sponsor:
Hospira
Pediatric Exclusivity Granted Date:
03/12/2013
NNPS:
FALSE'
Therapeutic Category:
Sedative
-
-